Correction: Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expressionTakashi Shimizu(Showa University), Toshiko Yamochi(Showa University)Frontiers in ImmunologyMarch 26, 202610.3389/fimmu.2026.1827736Cited by 0SaveCiteExport RISWatch citationsRelated PapersTumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression|Frontiers in Immunology|2025|3